99mtechnetium-HYNIC(tricine/TPPTS)-Aca-bombesin(7-14) as a targeted imaging agent with microSPECT in a PC-3 prostate cancer xenograft model

Molecular Pharmaceutics

Volumn 8, Issue 4, 2011, Pages 1165-1173

  Ananias, Hildo J K ^a   Yu, Zilin ^a   Dierckx, Rudi A ^a   Van Der Wiele, Christophe ^b   Helfrich, Wijnand ^a   Wang, Fan ^c   Yan, Yongjun ^d   Chen, Xiaoyuan ^d   De Jong, Igle J ^a   Elsinga, Philip H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c PEKING UNIVERSITY   (China)

^d NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

Author keywords

bombesin; cancer; GRP; GRPR; imaging; microSPECT; prostate; SPECT

Indexed keywords

6 HYDRAZINONICOTINIC ACID; AMINOCAPROIC ACID; BOMBESIN DERIVATIVE; BOMBESIN(7 14); GASTRIN RELEASING PEPTIDE RECEPTOR; NICOTINIC ACID; SULFONIC ACID DERIVATIVE; TECHNETIUM 99M; TRICINE AND TRISODIUM TRIPHENYLPHOSPHINE 3,3',3'' TRISULFONATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; DRUG DISTRIBUTION; DRUG STABILITY; DRUG SYNTHESIS; DRUG UPTAKE; HUMAN; HUMAN CELL; IC 50; MICRO SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR XENOGRAFT;

ANIMALS; BOMBESIN; CONTRAST MEDIA; HUMANS; MALE; MICE; MICE, NUDE; ORGANOTECHNETIUM COMPOUNDS; PROSTATIC NEOPLASMS; RADIOCHEMISTRY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79961080131     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp200014h     Document Type: Article

References (53)

1. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Thun, M. J. Cancer statistics, 2009 CA-Cancer J. Clin. 2009, 59, 225-249
2. Ferlay, J.; Parkin, D. M.; Steliarova-Foucher, E. Estimates of cancer incidence and mortality in Europe in 2008 Eur. J. Cancer 2010, 46, 765-781
3. Albertsen, P. C.; Hanley, J. A.; Harlan, L. C.; Gilliland, F. D.; Hamilton, A.; Liff, J. M.; Stanford, J. L.; Stephenson, R. A. The positive yield of imaging studies in the evaluation of men with newly diagnosed prostate cancer: a population based analysis J. Urol. 2000, 163, 1138-1143 (Pubitemid 30169379)
4. Hovels, A. M.; Heesakkers, R. A.; Adang, E. M.; Jager, G. J.; Strum, S.; Hoogeveen, Y. L.; Severens, J. L.; Barentsz, J. O. The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis Clin. Radiol. 2008, 63, 387-395
5. Zaheer, A.; Cho, S. Y.; Pomper, M. G. New agents and techniques for imaging prostate cancer J. Nucl. Med. 2009, 50, 1387-1390
6. Picchio, M.; Giovannini, E.; Messa, C. The role of PET/computed tomography scan in the management of prostate cancer Curr. Opin. Urol. 2011, 21, 230-236
7. Hong, H.; Zhang, Y.; Sun, J.; Cai, W. Positron emission tomography imaging of prostate cancer Amino Acids 2010, 39, 11-27
8. Beheshti, M.; Langsteger, W.; Fogelman, I. Prostate cancer: role of SPECT and PET in imaging bone metastases Semin. Nucl. Med. 2009, 39, 396-407
9. Ananias, H. J.; van den Heuvel, M. C.; Helfrich, W.; de Jong, I. J. Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer Prostate 2009, 69, 1101-1108
10. Markwalder, R.; Reubi, J. C. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation Cancer Res. 1999, 59, 1152-1159 (Pubitemid 29135980)
11. Reubi, J. C.; Wenger, S.; Schmuckli-Maurer, J.; Schaer, J. C.; Gugger, M. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14) Clin. Cancer Res. 2002, 8, 1139-1146 (Pubitemid 35177367)
12. Waser, B.; Eltschinger, V.; Linder, K.; Nunn, A.; Reubi, J. C. Selective in vitro targeting of GRP and NMB receptors in human tumours with the new bombesin tracer 177Lu-AMBA Eur. J. Nucl. Med. Mol. Imaging 2007, 34, 95-100 (Pubitemid 44885559)
13. Aprikian, A. G.; Cordon-Cardo, C.; Fair, W. R.; Reuter, V. E. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma Cancer 1993, 71, 3952-3965 (Pubitemid 23172976)
14. Cutz, E.; Chan, W.; Track, N. S. Bombesin, calcitonin and leu-enkephalin immunoreactivity in endocrine cells of human lung Experientia 1981, 37, 765-767 (Pubitemid 11045284)
15. Price, J.; Penman, E.; Wass, J. A.; Rees, L. H. Bombesin-like immunoreactivity in human gastrointestinal tract Regul. Pept. 1984, 9, 1-10 (Pubitemid 14004797)
16. Spindel, E. R.; Chin, W. W.; Price, J.; Rees, L. H.; Besser, G. M.; Habener, J. F. Cloning and characterization of cDNAs encoding human gastrin-releasing peptide Proc. Natl. Acad. Sci. U.S.A. 1984, 81, 5699-5703 (Pubitemid 14023833)
17. Ananias, H. J.; de Jong, I. J.; Dierckx, R. A.; Van de Wiele, C.; Helfrich, W.; Elsinga, P. H. Nuclear imaging of prostate cancer with gastrin-releasing-peptide-receptor targeted radiopharmaceuticals Curr. Pharm. Des 2008, 14, 3033-3047
18. Hohla, F.; Schally, A. V. Targeting gastrin releasing peptide receptors: New options for the therapy and diagnosis of cancer Cell Cycle 2010, 9, 1738-1741
19. Schroeder, R. P.; van Weerden, W. M.; Bangma, C.; Krenning, E. P.; de, J. M. Peptide receptor imaging of prostate cancer with radiolabelled bombesin analogues Methods 2009, 48, 200-204
20. De Vincentis, G.; Scopinaro, F.; Varvarigou, A.; Ussof, W.; Schillaci, O.; Archimandritis, S.; Corleto, V.; Longo, F.; Delle, F. G. Phase I trial of technetium [Leu13] bombesin as cancer seeking agent: possible scintigraphic guide for surgery? Tumori 2002, 88, S28-S30
21. De Vincentis, G.; Remediani, S.; Varvarigou, A. D.; Di Santo., G.; Iori, F.; Laurenti, C.; Scopinaro, F. Role of 99mTc-bombesin scan in diagnosis and staging of prostate cancer Cancer Biother. Radiopharm. 2004, 19, 81-84 (Pubitemid 38401047)
22. Scopinaro, F.; De Vincentis, G.; Varvarigou, A. D.; Laurenti, C.; Iori, F.; Remediani, S.; Chiarini, S.; Stella, S. 99mTc-bombesin detects prostate cancer and invasion of pelvic lymph nodes Eur. J. Nucl. Med. Mol. Imaging 2003, 30, 1378-1382 (Pubitemid 37247955)
23. Van de Wiele, C.; Dumont, F.; Vanden Broecke, R.; Oosterlinck, W.; Cocquyt, V.; Serreyn, R.; Peers, S.; Thornback, J.; Slegers, G.; Dierckx, R. A. Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study Eur. J. Nucl. Med. 2000, 27, 1694-1699
24. Van de Wiele, C.; Dumont, F.; Dierckx, R. A.; Peers, S. H.; Thornback, J. R.; Slegers, G.; Thierens, H. Biodistribution and dosimetry of (99m)Tc-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies J. Nucl. Med. 2001, 42, 1722-1727 (Pubitemid 33131335)
25. Liu, S.; Edwards, D. S. 99mTc-Labeled Small Peptides as Diagnostic Radiopharmaceuticals Chem. Rev. 1999, 99, 2235-2268
26. Wang, L.; Shi, J.; Kim, Y. S.; Zhai, S.; Jia, B.; Zhao, H.; Liu, Z.; Wang, F.; Chen, X.; Liu, S. Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers Mol. Pharmaceutics 2009, 6, 231-245
27. Liu, S.; Harris, A. R.; Williams, N. E.; Edwards, D. S. 99mTc-Labeling of a hydrazinonicotinamide-conjugated LTB(4) receptor antagonist useful for imaging infection and inflammation Bioconjugate Chem. 2002, 13, 881-886 (Pubitemid 34801132)
28. Edwards, D. S.; Liu, S.; Barrett, J. A.; Harris, A. R.; Looby, R. J.; Ziegler, M. C.; Heminway, S. J.; Carroll, T. R. New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc Bioconjugate Chem. 1997, 8, 146-154 (Pubitemid 27153287)
29. Shi, J.; Jia, B.; Liu, Z.; Yang, Z.; Yu, Z.; Chen, K.; Chen, X.; Liu, S.; Wang, F. (99m)Tc-Labeled Bombesin(7-14)NH2 with Favorable Properties for SPECT Imaging of Colon Cancer Bioconjugate Chem. 2008, 19, 1170-1178 (Pubitemid 351874939)
30. Guo, H.; Xie, F.; Zhu, M.; Li, Y.; Yang, Z.; Wang, X.; Lu, J. The synthesis of pteroyl-lys conjugates and its application as Technetium-99m labeled radiotracer for folate receptor-positive tumor targeting Bioorg. Med. Chem. Lett. 2011, 21, 2025-2029
31. Lu, J.; Pang, Y.; Xie, F.; Guo, H.; Li, Y.; Yang, Z.; Wang, X. Synthesis and in vitro/in vivo evaluation of (99m)Tc-labeled folate conjugates for folate receptor imaging Nucl. Med. Biol. 2011, 38, 557-565
32. Zhang, X.; Cai, W.; Cao, F.; Schreibmann, E.; Wu, Y.; Wu, J. C.; Xing, L.; Chen, X. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer J. Nucl. Med. 2006, 47, 492-501 (Pubitemid 46768492)
33. Chen, X.; Park, R.; Hou, Y.; Tohme, M.; Shahinian, A. H.; Bading, J. R.; Conti, P. S. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts J. Nucl. Med. 2004, 45, 1390-1397 (Pubitemid 47618540)
34. Fanger, B. O.; Wade, A. C.; Cardin, A. D. Characterization of the murine pancreatic receptor for gastrin releasing peptide and bombesin Regul. Pept. 1991, 32, 241-251
35. Faintuch, B. L.; Teodoro, R.; Duatti, A.; Muramoto, E.; Faintuch, S.; Smith, C. J. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies Nucl. Med. Biol. 2008, 35, 401-411 (Pubitemid 351637643)
36. Santos-Cuevas, C. L.; Ferro-Flores, G.; Arteaga de, M. C.; Pichardo-Romero, P. A. Targeted imaging of gastrin-releasing peptide receptors with 99mTc-EDDA/HYNIC-[Lys3]-bombesin: biokinetics and dosimetry in women Nucl. Med. Commun. 2008, 29, 741-747
37. Garcia-Garayoa, E.; Schweinsberg, C.; Maes, V.; Ruegg, D.; Blanc, A.; Blauenstein, P.; Tourwe, D. A.; Beck-Sickinger, A. G.; Schubiger, P. A. New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors Q. J. Nucl. Med. Mol. Imaging 2007, 51, 42-50 (Pubitemid 46830276)
38. Garcia-Garayoa, E.; Ruegg, D.; Blauenstein, P.; Zwimpfer, M.; Khan, I. U.; Maes, V.; Blanc, A.; Beck-Sickinger, A. G.; Tourwe, D. A.; Schubiger, P. A. Chemical and biological characterization of new Re(CO)3/[99mTc](CO)3 bombesin analogues Nucl. Med. Biol. 2007, 34, 17-28 (Pubitemid 46038151)
39. Lantry, L. E.; Cappelletti, E.; Maddalena, M. E.; Fox, J. S.; Feng, W.; Chen, J.; Thomas, R.; Eaton, S. M.; Bogdan, N. J.; Arunachalam, T.; Reubi, J. C.; Raju, N.; Metcalfe, E. C.; Lattuada, L.; Linder, K. E.; Swenson, R. E.; Tweedle, M. F.; Nunn, A. D. 177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer J. Nucl. Med. 2006, 47, 1144-1152 (Pubitemid 47558898)
40. Maina, T.; Nock, B. A.; Zhang, H.; Nikolopoulou, A.; Waser, B.; Reubi, J. C.; Maecke, H. R. Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs J. Nucl. Med. 2005, 46, 823-830
41. Zhang, H.; Schuhmacher, J.; Waser, B.; Wild, D.; Eisenhut, M.; Reubi, J. C.; Maecke, H. R. DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours Eur. J. Nucl. Med. Mol. Imaging 2007, 34, 1198-1208 (Pubitemid 47296770)
42. Mansi, R.; Wang, X.; Forrer, F.; Waser, B.; Cescato, R.; Graham, K.; Borkowski, S.; Reubi, J. C.; Maecke, H. R. Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours Eur. J. Nucl. Med. Mol. Imaging 2011, 38, 97-107
43. Koumarianou, E.; Mikolajczak, R.; Pawlak, D.; Zikos, X.; Bouziotis, P.; Garnuszek, P.; Karczmarczyk, U.; Maurin, M.; Archimandritis, S. C. Comparative study on DOTA-derivatized bombesin analog labeled with 90Y and 177Lu: in vitro and in vivo evaluation Nucl. Med. Biol. 2009, 36, 591-603
44. Nock, B.; Nikolopoulou, A.; Chiotellis, E.; Loudos, G.; Maintas, D.; Reubi, J. C.; Maina, T. [99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging Eur. J. Nucl. Med. Mol. Imaging 2003, 30, 247-258 (Pubitemid 36686844)
45. Cescato, R.; Maina, T.; Nock, B.; Nikolopoulou, A.; Charalambidis, D.; Piccand, V.; Reubi, J. C. Bombesin receptor antagonists may be preferable to agonists for tumor targeting J. Nucl. Med. 2008, 49, 318-326 (Pubitemid 351225672)
46. Schroeder, R. P.; Muller, C.; Reneman, S.; Melis, M. L.; Breeman, W. A.; de, B. E.; Bangma, C. H.; Krenning, E. P.; van Weerden, W. M.; de, J. M. A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues Eur. J. Nucl. Med. Mol. Imaging 2010, 37, 1386-1396
47. Dearling, J. L.; Flynn, A. A.; Sutcliffe-Goulden, J.; Petrie, I. A.; Boden, R.; Green, A. J.; Boxer, G. M.; Begent, R. H.; Pedley, R. B. Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts J. Nucl. Med. 2004, 45, 101-107 (Pubitemid 47611615)
48. Bao, A.; Phillips, W. T.; Goins, B.; McGuff, H. S.; Zheng, X.; Woolley, F. R.; Natarajan, M.; Santoyo, C.; Miller, F. R.; Otto, R. A. Setup and characterization of a human head and neck squamous cell carcinoma xenograft model in nude rats Otolaryngol. Head Neck Surg. 2006, 135, 853-857 (Pubitemid 44820627)
49. Honer, M.; Mu, L.; Stellfeld, T.; Graham, K.; Martic, M.; Fischer, C. R.; Lehmann, L.; Schubiger, P. A.; Ametamey, S. M.; Dinkelborg, L.; Srinivasan, A.; Borkowski, S. 18F-labeled bombesin analog for specific and effective targeting of prostate tumors expressing gastrin-releasing peptide receptors J. Nucl. Med. 2011, 52, 270-278
50. Lane, S. R.; Nanda, P.; Rold, T. L.; Sieckman, G. L.; Figueroa, S. D.; Hoffman, T. J.; Jurisson, S. S.; Smith, C. J. Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7-14)NH2], in a prostate tumor xenografted mouse model Nucl. Med. Biol. 2010, 37, 751-761
51. Mansi, R.; Wang, X.; Forrer, F.; Kneifel, S.; Tamma, M. L.; Waser, B.; Cescato, R.; Reubi, J. C.; Maecke, H. R. Evaluation of a 1,4,7,10- tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides Clin. Cancer Res. 2009, 15, 5240-5249
52. Lears, K. A.; Ferdani, R.; Liang, K.; Zheleznyak, A.; Andrews, R.; Sherman, C. D.; Achilefu, S.; Anderson, C. J.; Rogers, B. E. In vitro and in vivo evaluation of 64Cu-labeled SarAr-bombesin analogs in gastrin-releasing peptide receptor-expressing prostate cancer J. Nucl. Med. 2011, 52, 470-477
53. Surfraz, M. B.; King, R.; Mather, S. J.; Biagini, S.; Blower, P. J. Technetium-binding in labelled HYNIC-peptide conjugates: role of coordinating amino acids J. Inorg. Biochem. 2009, 103, 971-977